NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis
“Based on the data, NanoBio will move immediately to initiate plans to begin phase 3 testing of NB-001 in early 2009.”
NanoBio Corporation reported top-level findings today from its phase 2b study of NB-001, a topical lotion to treat herpes labialis . via Earth Times
If you enjoyed this post, make sure you subscribe to my RSS feed!
